Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108239019A enables enzymatic synthesis of chiral piperidine esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112538033A details a Pd-catalyzed kinetic resolution method yielding high-purity chiral cyclophanes with superior enantioselectivity and scalability.
Patent CN116396189A details a novel B(C6F5)3 catalyzed route for high-purity (S)-(+)-1-indanyl isocyanate, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Advanced patent-based method for solifenacin intermediate production offering high purity and reduced waste for global pharmaceutical supply chains.
Novel patent CN121342695A offers scalable chiral amino acid synthesis. Reduces waste and cost for IL-17 inhibitor intermediates. Reliable supply chain partner.
Patent CN109503462B details a novel synthesis for Tofacitinib intermediates, offering improved stereoselectivity and cost reduction in API manufacturing through optimized catalytic hydrogenation.
Patent CN108912032A details an efficient seven-step synthesis for chiral pyrrolidine derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109734653B details a superior chiral resolution method for Argatroban precursors using L-dibenzoyltartaric acid, offering enhanced purity and cost-effective manufacturing scalability.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Patent CN119306645A reveals advanced pyrrolamide synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable, high-yield processes.
Patent CN116396189B details a novel boron-catalyzed route for high-purity chiral intermediates, offering significant supply chain stability and cost optimization for global pharmaceutical manufacturers.
Patent CN113896645A reveals a one-pot synthesis method for D-p-HPG. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1915974A details NMP-based chiral resolution for high-purity Amlodipine. Offers significant cost reduction and supply chain reliability for API manufacturing partners.
Patent CN107151246B reveals cost-effective chiral resolution. Reliable supplier for high-purity levo-praziquantel intermediates with scalable processes.
Patent CN106008316B enables cost-effective Ledipasvir intermediate production. Discover scalable synthesis routes for high-purity pharmaceutical intermediates supply.
Novel resolution process enhances purity and supply continuity for D-Calcium Pantothenate manufacturing reducing costs significantly for global buyers.
Patent CN115197115B reveals novel chiral synthesis. Enables cost reduction and high purity for pharmaceutical intermediates manufacturing supply chains.
Patent CN112479876B details a novel chiral resolution method for oxazepane spiro compounds, offering improved stereoselectivity and streamlined manufacturing for global supply chains.
Novel synthesis route for chiral nitrophenol intermediates reduces cost and improves purity. Reliable supply for pharmaceutical manufacturing scale-up.
Advanced preparation method for (R)-1-Boc-3-aminopiperidine via chiral resolution. Safe, scalable process for DPP-IV inhibitor intermediates with reduced costs.